Im here by default and previous sheet management. Expenses are out of sync with the company valuation and any CR will be whittled away in salaries.Value is a qtr of the listing price and not a good prospect for my money.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025